Tscan TherapeuticsTCRX
13F holders, Q2 2026 (June 30)60holders
6new positions
7sold out
4famous investors
$0.98avg. 13F price*
At the end of Q2 2026, 60 institutions reported holding Tscan Therapeutics Inc. (TCRX) in their 13F filings, unchanged from Q1 2026. 6 opened new positions and 7 sold out. The largest holders were Lynx1 Capital Management LP ($7.9M), BVF Inc. ($5.5M) and Baker Bros. Advisors LP ($2.7M). 4 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Tscan Therapeutics Inc.
- CUSIP
- 89854M101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $1.6M |
| Exits | 7 | $1.1M |
All 13F filers, Q1 2026 → Q2 2026: 5,779,102 shares bought and 2,456,557 shares sold, net +3,322,545 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 60 holders
| Lynx1 Capital Management LP | 0.91% | No change | 8,019,148 | $7.9M |
| BVF Inc. | 0.14% | No change | 5,564,290 | $5.5M |
| Baker Bros. Advisors LP | 0.01% | No change | 2,784,792 | $2.7M |
| Vanguard Capital Management LLC | 0.00% | Add +0.2% | 2,158,831 | $2.1M |
| Two Sigma Investments, LP | 0.00% | Add +61.3% | 1,949,604 | $1.9M |
| Renaissance Technologies | 0.00% | Reduce -2.8% | 1,326,799 | $1.3M |
| Acadian Asset Management LLC | 0.00% | Add +546.5% | 1,305,840 | $1.3M |
| Deer Management Co. LLC | 0.15% | No change | 1,245,504 | $1.2M |
| Millennium Management | 0.00% | Reduce -20.3% | 1,163,611 | $1.1M |
| Jacobs Levy Equity Management, Inc. | 0.00% | Add +29.9% | 1,049,806 | $1.0M |
| Citadel Advisors | 0.00% | Add +216.9% | 1,009,107 | $989K |
| BlackRock, Inc. | 0.00% | Reduce -46.0% | 994,654 | $975K |
| Boothbay Fund Management, LLC | 0.01% | New | 772,241 | $757K |
| Marshall Wace, LLP | 0.00% | Add +189.6% | 687,364 | $674K |
| DC Funds, LP | 49.27% | No change | 630,000 | $617K |
| Geode Capital Management, LLC | 0.00% | Reduce -5.2% | 584,811 | $573K |
| D. E. Shaw & Co. | 0.00% | Add +71.6% | 548,402 | $537K |
| Gsa Capital Partners LLP | 0.03% | Add +44.6% | 548,087 | $537K |
| Kalehua Capital Management LLC | 0.26% | New | 454,876 | $446K |
| Vanguard Fiduciary Trust Co. | 0.00% | Add +19.0% | 363,954 | $357K |
| Jane Street Group, LLC | 0.00% | Add +67.2% | 241,493 | $237K |
| Verdad Advisers, LP | 0.22% | Add +73.7% | 232,759 | $228K |
| State Street Corp. | 0.00% | No change | 207,313 | $203K |
| Mizuho Securities USA LLC | 0.00% | New | 205,600 | $202K |
| Morgan Stanley | 0.00% | Add +14.0% | 197,891 | $194K |
| HRT Financial LP | 0.00% | New | 164,601 | $161K |
| XTX Topco Ltd | 0.00% | Add +146.2% | 149,467 | $146K |
| Brown Brothers Harriman & Co. | 0.00% | No change | 143,051 | $140K |
| Northern Trust Corp. | 0.00% | Add +42.4% | 138,778 | $136K |
| Letko, Brosseau & Associates Inc. | 0.00% | No change | 95,875 | $94K |
| NewEdge Wealth, LLC | 0.00% | No change | 91,463 | $90K |
| Bridgeway Capital Management, LLC | 0.00% | Reduce -31.3% | 76,900 | $75K |
| Goldman Sachs Group Inc. | 0.00% | Add +89.2% | 70,514 | $69K |
| Ameriprise Financial Inc. | 0.00% | Add +32.0% | 69,487 | $68K |
| UBS Group AG | 0.00% | Add +112.0% | 68,873 | $67K |
| Stifel Financial Corp. | 0.00% | Reduce -1.7% | 68,200 | $67K |
| Dimensional Fund Advisors LP | 0.00% | No change | 65,335 | $64K |
| Kestra Advisory Services, LLC | 0.00% | No change | 62,525 | $61K |
| Bank of America Corp. | 0.00% | Reduce -14.7% | 49,100 | $48K |
| Public Employees Retirement System of Ohio | 0.00% | Add +32.1% | 36,600 | $36K |
| DC Investments Management, LLC | 0.01% | No change | 35,563 | $35K |
| Landscape Capital Management, L.L.C. | 0.00% | New | 25,864 | $25K |
| HSBC Holdings PLC | 0.00% | No change | 24,574 | $24K |
| Susquehanna International Group, LLP | 0.00% | Reduce -85.0% | 23,623 | $23K |
| Barclays PLC | 0.00% | Add +12.2% | 19,170 | $19K |
| R Squared Ltd | 0.01% | New | 18,360 | $18K |
| Vanguard Personalized Indexing Management, LLC | 0.00% | Reduce -15.9% | 17,959 | $18K |
| JPMorgan Chase & Co. | 0.00% | Add +0.1% | 16,458 | $16K |
| Vanguard Global Advisers, LLC | 0.00% | No change | 15,705 | $15K |
| Osaic Holdings, Inc. | 0.00% | Add +25.5% | 12,245 | $12K |
| Aries Wealth Management | 0.00% | No change | 10,000 | $10K |
| Global Retirement Partners, LLC | 0.00% | — | 10,000 | $10K |
| Federated Hermes, Inc. | 0.00% | Reduce -7.3% | 3,982 | $4K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -49.6% | 2,549 | $2K |
| FMR LLC | 0.00% | Add +7.7% | 1,400 | $1K |
| BNP Paribas Financial Markets | 0.00% | No change | 713 | $699 |
| SBI Securities Co., Ltd. | 0.00% | No change | 392 | $384 |
| Strategic Wealth Partners, Ltd. | 0.00% | No change | 311 | $305 |
| Caitong International Asset Management Co., Ltd | 0.00% | Reduce -50.0% | 1 | $1 |
| Royal Bank of Canada | 0.00% | Add +6.8% | 78 | $0 |
"% of holder's portfolio" is TCRX's weight in each manager's 13F, not the share of Tscan Therapeutics Inc. the manager owns.